Predicting the Genetic Makeup of FDA

DSpace/Manakin Repository

Predicting the Genetic Makeup of FDA

Citable link to this page

. . . . . .

Title: Predicting the Genetic Makeup of FDA
Author: Yang, Tamara J.
Citation: Predicting the Genetic Makeup of FDA (2000 Third Year Paper)
Full Text & Related Files:
Abstract: Genetic testing holds promise as the either the most beneficial or the most destructive creation of the new millennium. The consequences of genetic testing research are far-reaching, with the potential for finding cures to diseases such as cancer, or destroying an individual's life by changing insurance ratings, employment opportunities, and reproductive decisions. The scientific, legal, socioeconomic, and ethical implications of genetic testing demand appropriate regulatory controls. The responsibility of regulation falls on various governmental agencies, including the Food and Drug Administration (FDA). However, the neophyte genetics industry, ever evolving through biotechnological developments, does not have sufficient safeguards to meet the challenges posed by the impending completion of the Human Genome Project. Whether FDA is the appropriate regulatory body to solve these imminent problems is a question requiring a detailed exploration of genetic testing, the Human Genome Project, FDA's history, current regulation of genetic testing, critiques of FDA involvement, and alternative solutions.
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:8963874

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters